UnknownNot Applicable

Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France

France150 participantsStarted 2015-08-13

Plain-language summary

This study aims to investigate the factors (clinical, care-related and genetic) affecting renal outcome in patients with TSC (Tuberous sclerosis complex)

Who can participate

Age range8 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria of study participants * Patient presenting with an isolated angiomyolipoma or * Patient presenting with tuberous sclerosis complex combined with an angiomyolipoma or * Patient presenting with tuberous sclerosis complex * Patient not objecting to the study Exclusion criteria of study participants ■Patient objecting to the study

What they're measuring

Evolution of the renal function estimated by the MDRD GFR

Timeframe: 18 months after inclusion

Trial details

NCT IDNCT02887781

SponsorUniversity Hospital, Brest

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-31

Contact for this trial

Yannick LE MEUR, MD PhD

yannick.lemeur@chu-brest.fr

View on ClinicalTrials.gov More Tuberous Sclerosis Complex trials